Literature DB >> 6605717

Intermittent chemoprophylaxis for Pneumocystis carinii pneumonia.

W T Hughes, B L Smith.   

Abstract

An intermittent regimen of trimethoprim-sulfamethoxazole was tested in the corticosteroid-treated rat model to learn whether or not administration for 3 consecutive days a week would provide prophylaxis equal to continuous daily doses. Although all of the untreated control animals acquired Pneumocystis carinii pneumonia, none of the animals given either continuous or intermittent trimethoprim-sulfamethoxazole became infected.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605717      PMCID: PMC185158          DOI: 10.1128/AAC.24.2.300

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.

Authors:  W T Hughes; S Feldman; S C Chaudhary; M J Ossi; F Cox; S K Sanyal
Journal:  J Pediatr       Date:  1978-02       Impact factor: 4.406

2.  Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii.

Authors:  W T Hughes
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

3.  Natural mode of acquisition for de novo infection with Pneumocystis carinii.

Authors:  W T Hughes
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

4.  Chemoprophylaxis for Pneumocystis carinii pneumonitis: outcome of unstructured delivery.

Authors:  R B Wilber; S Feldman; W J Malone; M Ryan; R J Aur; W T Hughes
Journal:  Am J Dis Child       Date:  1980-07

5.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Kuhn; S Chaudhary; S Feldman; M Verzosa; R J Aur; C Pratt; S L George
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

6.  Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; P C McNabb; T D Makres; S Feldman
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

  6 in total
  4 in total

Review 1.  Prevention of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

2.  Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.

Authors:  R G D'Antonio; D B Johnson; R E Winn; A F van Dellen; M E Evans
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

3.  Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice.

Authors:  P D Walzer; C K Kim; M J Linke; C L Pogue; M J Huerkamp; C E Chrisp; A V Lerro; S K Wixson; E Hall; L D Shultz
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

Review 4.  Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs.

Authors:  P D Walzer; J Foy; P Steele; M White
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.